Summary
We have observed that phospholipids and protein of the catecholamine (CA) storage granules, i.e. the chromaffin granules, interact in anin vitro system to form liposomal particles, which in many respects resemble the intact matrix of the bovine chromaffin granule. A model has been suggested which consists of an aqueous phase, containing the acidic chromogranins and intact dopamine-β-hydroxylase (DBH) ATP and CA, embedded in a liquid crystal of the matrix phospholipids. Ca2+ may play a significant role in the sequence of functional transitions of such an organelle, not only in the accumulation of Ca2+, as during the secretory phase of the intact cell, but also as the agent inducing a separation of the outer membrane bilayer from the matrix phase to be released, as during exocytosis. Furthermore, a liposome model of the matrix may also tentatively explain the occurrence of intact matrices in the interstitium of stimulated glands.
Recent evidence for the identity between chromogranin A and DBH subunits have been summarized and a possible role for the inactive subunits in the ionic binding of ATP and CA in the aqueous phase of the matrix is discussed.
A role of Ca2+ and cyclic AMP in the mediation ofβ-adrenergic modulation is postulated on the basis of our recent work on acetylcholine-induced release of CA from perfused and stimulated bovine adrenals. We conclude that such aβ-adrenergic modulation is secondary to that of the cholinergic response. Hence, this activation is able to enhance the output induced by mild cholinergic stimulation although insufficient to evoke a CA release by itself.
Similar content being viewed by others
References
P. Banks, Calcium and Cellular Functions (Cuthbert, A. W., ed.) pp. 148–162, Macmillan and Co., London 1970.
R. P. Rubin, Pharmacol. Rev. 22, 389–428 (1970).
L. B. Geffen and B. G. Livett, Physiol. Rev. 51, 98–157 (1972).
L. Stjärne, Handbuch der experimentellen Pharmakologie (Blaschko, H. and Muscholl, E., eds.) XXXIII, pp. 231–269, Springer Verlag, Heidelberg 1972.
A. D. Smith and H. Winkler, Handbuch der experimentellen Pharmakologie (Blaschko, H. and Muscholl, E., eds.) XXXIII, pp. 538–617, Springer Verlag, Heidelberg 1972.
W. W. Douglas, Brit. J. Pharmacol. 34, 451–474 (1968).
H. Blaschko, R. C. Comline, F. Schneider, M. Silver and A. D. Smith, Nature (Lond.) 215, 58–59 (1967).
N.-Å. Hillarp, Adrenergic Mechanism, Ciba Found. Symp. (Wolstenholme, G. E. W. and O'Conner, M. O., eds.) pp. 481, Churchill, London 1960.
H. Blaschko, C. V. Born, A. D'Iorio and N. Eade, J. Physiol. (Lond.) 133, 548–557 (1956).
N.-Å. Hillarp, Acta physiol. scand. 47, 271–275 (1959).
H. Blaschko and K. B. Helle, J. Physiol. (Lond.) 169, 120P (1963).
K. B. Helle, Studies of Chromogranin A, Universitetsfor-laget, Bergen 1971.
K. H. Berneis, A. Pletcher and M. DaPrada, Nature (Lond.) 224, 281–283 (1969).
K. B. Helle, Biochim. Biophys. Acta 318, 181–196 (1973).
K. B. Helle and G. Serck-Hanssen, Frontiers in Catechol-amine Research (Usdin, E. and Snyder, S. H., eds.) pp. 467–469, Pergamon Press, New York 1973.
G. Serck-Hanssen and E. N. Christiansen, Biochim. Biophys. Acta 307, 404–414 (1973).
G. Serck-Hanssen, Biochem. Pharmacol. 23, 2225–2234 (1974).
C. F. Poyart, J. Papayoanou and G. G. Nahas, J. Physiol. (Paris) 60, suppl., 523 (1968).
K. B. Helle and G. Serck-Hanssen, Pharmacol. Res. Comm. 1, 25–29 (1969).
K. B. Helle, Mol. Pharmacol. 2, 298–310 (1966).
K. B. Helle, Biochim. Biophys. Acta 245, 80–93 (1971).
G. Serck-Hanssen, Biochem. Pharmacol. 20, 361–373 (1971).
G. Serck-Hanssen, Acta physiol. scand. 86, 289–298 (1972).
Å. Bertler, A. Carlsson and E. Rosengren, Acta physiol. scand. 44, 273–292 (1958).
O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, J. Biol. Chem. 193, 265–275 (1951).
J. W. Gibb, S. Spector and S. Udenfriend, Mol. Pharmacol. 3, 473–478 (1967).
K. B. Helle, Biochim. Biophys. Acta 117, 107–110 (1966).
K. B. Helle, T. Flatmark, G. Serck-Hanssen and S. Lönning, Biochim. Biophys. Acta 226, 1–9 (1971).
K. B. Helle, Biochim. Biophys. Acta 318, 167–180 (1973).
M. Vulpian, C.R. Acad. Sci. (Paris) 43, 663 (1856).
F. Stolz, Ber. Deutsch. Chem. Gesellsch. 37, 4149–4154 (1904).
H. Blaschko and A. D. Welch, Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 219, 17–22 (1953).
N.-Å. Hillarp, S. Lagerstedt and B. Nilson, Acta physiol. scand. 29, 251–263 (1953).
P. Banks, Biochem. J. 95, 490–496 (1965).
A. D. Smith and H. Winkler, Biochem. J. 103, 483–492 (1967).
W. J. Smith and N. Kirshner, Mol. Pharmacol. 3, 52–62 (1967).
R. E. Coupland, Nature (Lond.) 217, 384–388 (1968).
R. E. Coupland and D. Hopwood, J. Anat. 100, 227 (1966).
R. E. Coupland, Subcellular Organization and Function in Endocrine Tissues. Mem. Soc. Endocrin., 19 (Heller, H. and Lederis, K., eds.) pp. 611–633, Cambridge University Press 1971.
B. Agostini and G. Taugner, Histochemie 33, 255–272 (1973).
H. Lagercrantz, L. Stjärne, T. Flatmark and K. B. Helle, Biochem. Pharmacol. 22, 3005–3011 (1973).
F. H. Schneider, A. D. Smith and H. Winkler, Br. J. Pharmacol. Chemother. 31, 94–104 (1967).
H. Winkler, Phil. Trans. Roy. Soc. Lond. B, 261, 293–303 (1971).
F. H. Schneider, Biochem. Pharmacol. 21, 2627–2634 (1972).
K. B. Helle, Biochem. J. 109, 43P-44P (1968).
R. Myroie and H. Koenig, FEBS Letters 12, 121–124 (1971).
K. B. Helle, Biochim. Biophys. Acta 245, 94–104 (1971).
G. Taugner and A. Wähler, Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 261–278 (1974).
G. Taugner and A. Wähler, Naunyn-Schniedeberg's Arch. Pharmacol. 282, 279–293 (1974).
W. Stoeckenius, J. Cell. Biol. 12, 221–229 (1962).
O. Diner, C.R. Acad. Sci. Paris 265D, 616–619 (1967).
L. G. Elfwin, J. Ultrastruct. 12, 263–286 (1965).
J. L. Borowitz, K. Fuwa and N. Weiner, Nature (Lond.) 205, 42–43 (1965).
J. L. Borowitz, Biochem. Pharmacol. 18, 715–723 (1969).
R. G. Rahwan and J. L. Borowitz, J. Pharmac. Sci. 62, 1911–1923 (1973).
K. H. Berneis, M. DaPrada and A. Pletcher, Nature (Lond.) 248, 604–605 (1974).
J. M. Trifaró, Frontiers in Catecholamine Research (Usdin, E. and Snyder, S. H., eds.) pp. 501–503, Pergamon Press, New York 1973.
J. T. Buckley and J. N. Hawthorne, J. Biol. Chem. 247, 7218–7223 (1972).
P. Laduron and F. Belpaire, Biochem. Pharmacol. 17, 1127–1140 (1968).
K. B. Helle, New Aspects of Storage and Release Mechanisms of Catecholamines Bayer Symp. II (Schümann, H. J. and Kroneberg, G., eds.) pp. 45–56, Springer Verlag, Berlin 1970.
A. Kirshner and N. Kirshner, Biochim. Biophys. Acta 181, 219–225 (1969).
H. Hörtnagl, H. Lochs and H. Winkler, J. Neurochem. 22, 197–199 (1974)
H. Hörtnagl, H. Winkler and H. Lochs, Biochem. J. 129, 187–195 (1972).
H. Winkler and H. Hörtnagl, Frontiers in Catecholamine Research (Usdin, E. and Snyder, S. H., eds.) pp. 415–421, Pergamon Press, New York 1973.
T. Silsand and T. Flatmark, Biochim. Biophys. Acta, 359, 257–266 (1974).
A. Foldes, P. L. Jeffrey, B. N. Preston and L. Austin, Biochem. J. 123, 1209–1217 (1972).
S. Friedman and S. Kaufman, J. Biol. Chem. 240, 4763–4773 (1965).
E. F. Wallace, M. J. Frantz and W. Lovenberg, Proc. Natl. Acad. Sci., U.S. 70, 2253–2255 (1973).
D. Aunis, M.-T. Miras-Portugal and P. Mandel, Biochim. Biophys. Acta 327, 313–327 (1973).
D. Aunis, M.-T. Miras-Portugal and P. Mandel, Biochim. Biophys. Acta 365, 259–273 (1974).
J. E. Craine, G. H. Daniels and S. Kaufman, J. Biol. Chem. 248, 7838–7844 (1973).
A. Foldes, P. L. Jeffrey, B. N. Preston and L. Austin, J. Neurochem. 20, 1431–1442 (1973).
P. Banks, Biochem. J. 101, 536–541 (1966).
W. W. Douglas and A. M. Poisner, J. Physiol. (Lond.) 183, 249–256 (1966).
P. Banks and K. B. Helle, Biochem. J. 97, 40C-41C (1965).
O. H. Viveros, L. Arqueros and N. Kirshner, Life Sciences 7, 609–618 (1968).
E. D. P. De Robertis and A. Vaz Ferreira, Exp. Cell. Res. 12, 568–574 (1957).
O. H. Viveros, L. Arqueros and N. Kirshner, Science 165, 911–913 (1969).
T. A. Slotkin and N. Kirshner, Biochem. Pharmacol. 22, 205–219 (1973).
R. A. Rush and L. B. Geffen, Circ. Rec. 31, 444–452 (1972).
J. M. Trifaró, A. M. Poisner and W. W. Douglas, Biochem. Pharmacol. 16, 2095–2100 (1967).
A. M. Poisner, J. M. Trifaró and W. W. Douglas, Biochem. Pharmacol. 16, 2101–2108 (1967).
G. Serck-Hanssen, Acta physiol. scand. suppl. 330, abstr. 63 (1969).
O. H. Viveros, L. Arqueros and N. Kirshner, Mol. Pharmacol. 5, 342–349 (1969).
I. Benedeczky and A. D. Smith, Z. Zellforsch. 124, 367–386 (1972).
A. M. Poisner, Advances in Biochemical Psychopharmacology, (Costa, E. and Giacobini, E., eds.) Vol. 2, pp. 95–108, Raven Press, New York 1970.
S. Berl, S. Puszkin and W. J. Nicklas, Science 179, 441–446 (1973).
P. Banks, Biochem. J. 101, 18C-20C (1966).
A. M. Poisner and M. Hava, Mol. Pharmacol. 6, 407–415 (1970).
F. Izumi, M. Oka and T. Kashimoto, Med. J. Osaka Univ. 21, 241–249 (1971).
M. J. Peach, Proc. Natl. Acad. Sci., U.S. 69, 834–836 (1972).
S. D. Jaanus and R. P. Rubin, J. Physiol. (Lond.) 237, 465–476 (1974).
G. Serck-Hanssen, T. Christoffersen, J. Mörland and J.-B. Osnes, Eur. J. Pharmacol. 19, 297–300 (1972).
A. Guidotti, B. Zivkovic, R. Pfeiffer and E. Costa, Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 193–206 (1973).
E. Bülbring, J. H. Burn and F. J. DeElio, J. Physiol. (Lond.) 107, 222–232 (1948).
J. Malméjac, J. Physiol. (Lond.) 130, 497–512 (1955).
G. Serck-Hanssen Sövik, Dissertation Thesis, University of Oslo, 1974.
E. Costa and A. Guidotti, New Concepts of Neurotransmitter Regulation (A. J. Mandell, ed.) pp. 135–152, Plenum Publ. Corp., New York-London 1973.
A. Guidotti and E. Costa, Science 179, 902–904 (1973).
T. Deguchi and J. Axelrod, Proc. Natl. Acad. Sci., U.S. 69, 2208–2211 (1972).
D. C. Klein and J. L. Weller, J. Pharm. Exp. Ther. 186, 516–527 (1973).
U. Otten, F. Oesch and H. Thoenen, Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 129–140 (1973).
I. B. Black, J. A. Hendry and L. L. Iversen, Nature, New Biol. (Lond.) 231, 27–29 (1971).
H. Thoenen, R. Kettler, W. Burkard and A. Saner, Naunyn-Schmiedeberg's Arch. Pharmacol. 270, 146–160 (1971).
G. Serck-Hanssen, unpublished results, 1968.
A. Guidotti, C. C. Mao and E. Costa, Frontiers in Catecholamine Research (Usdin, E. and Snyder, S. H., eds.) pp. 231–236, Pergamon Press, New York 1973.
J. Häggendal, New Aspects of Storage and Release Mechanisms of Catecholamines, Bayer Symp. II, (Schümann, H.J. and Kroneberg, G., eds.) pp. 100–109, Springer Verlag, Berlin 1970.
F. Z. Langer, E. Adler, M. A. Enero and F. J. E. Stefano, XXVth Int. Congr. Physiol. Sci. p. 335 (1971).
K. Starke, Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 11–23 (1972).
R. E. Coupland, The Natural History of the Chromaffin Cell, 279 pp., Longmans, London 1965.
F. D. Prentice and J. G. Wood, Anat. Rec. 178, 441 (1974).
A. G. E. Pearse, J. Histochem. Cytochem. 17, 303–313 (1969).
W. F. Ganong, Fedn. Proc. 32, 1782–1784 (1973).
D. Porte and R. P. Robertson, Fedn. Proc. 32, 1792–1796 (1973).
J. F. Kuo and P. Greengard, Proc. Natl. Acad. Sci., U.S. 64, 1349–1355 (1969).
F. Labrie, S. Lemaire, G. Poirier, G. Pelletier and R. Boucher, J. Biol. Chem. 246, 7311–7317 (1971).
J. M. Trifaró and J. Dworkind, Mol. Pharmacol. 7, 52–65 (1971).
J. T. Stull, C. O. Brostrom and E. G. Krebs, J. Biol. Chem. 247, 5272–5274 (1972).
Author information
Authors and Affiliations
Additional information
An invited article.
Rights and permissions
About this article
Cite this article
Helle, K.B., Serck-Hanssen, G. The adrenal medulla: A model for studies of hormonal and neuronal storage and release mechanisms. Mol Cell Biochem 6, 127–146 (1975). https://doi.org/10.1007/BF01732006
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01732006